Aurobindo Pharma reports 10% fall in Q3 consolidated net profit

07 Feb 2025 Evaluate

Aurobindo Pharma has reported results for third quarter ended December 31, 2024 (Q3FY25). 

The company has reported 24.32% decline in its net profit at Rs 472.05 crore for Q3FY25 as compared to Rs 623.77 crore for the same quarter in the previous year. Total income of the company decreased marginally by 1.73% at Rs 2970.89 crore for Q3FY25 as compared to Rs 3023.30 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 10.04% decline in its net profit at Rs 845.57 crore for the quarter ended December 31, 2024 as compared to Rs 939.97 crore for the same quarter in the previous year. However, total income of the company increased by 8.27% at Rs 8135.81 crore for Q3FY25 as compared to Rs 7514.30 crore for the corresponding quarter previous year.


Aurobindo Pharma Share Price

1171.40 9.55 (0.82%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×